Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bemcentinib + SoC in Advanced Melanoma
NCT02872259Phase 2Completed
- Sponsor
- Haukeland University Hospital
- Start
- Feb 2017
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bemcentinib in melanoma, sponsored by Haukeland University Hospital. Started Feb 2017; status: completed.
02
Drugs
bemcentinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02872259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872259.